Pulmonary Disease, Chronic Obstructive
Conditions
Brief summary
A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment
Interventions
BEHAVIORALEducation
Sponsors
Boehringer Ingelheim
Eligibility
Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* COPD patients over 35 years of age * More than two annual renewals with the following group of inhalation preparations: Anticholinergic, beta-2 antagonists, steroids or a combination of these
Exclusion criteria
* Asthma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To focus on implementation of national guidelines for diagnosis and treatment of COPD | Up to 1.2 years |
| To optimise the diagnosis and treatment of COPD via a quality assurance project | Up to 1.2 years |
| Increase the knowledge and use of diagnostic tools and treatment amongst PCPs | Up to 1.2 years |
Outcome results
None listed